Evidence map›Paper›PMID 42609955›Full record

ArticleBiomedical optics express2026

1064 nm-absorbing semiconducting polymer nanoparticles for multimodal photoacoustic and fluorescence imaging.

Takeshi Hirasawa, Takahiro Sato, Saya Akasaka, Yuya Yoshimoto, Tomohiro Ishikawa, Ryo Shintate, Manami Miyashita, Yoshiaki Tsubata, Kouichi Saito, Miya Ishihara

Abstract read
In one paragraph

Article in Biomedical optics express, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Takeshi HirasawaDepartment of Medical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.ORCID https://orcid.org/0000-0002-6769-4065
Takahiro SatoAdvanced Materials Development Laboratory, Sumitomo Chemical Co., Ltd., 6, Kitahara, Tsukuba, Ibaraki, 300-3294, Japan.
Saya AkasakaAdvanced Materials Development Laboratory, Sumitomo Chemical Co., Ltd., 6, Kitahara, Tsukuba, Ibaraki, 300-3294, Japan.
Yuya YoshimotoAdvanced Materials Development Laboratory, Sumitomo Chemical Co., Ltd., 6, Kitahara, Tsukuba, Ibaraki, 300-3294, Japan.
Tomohiro IshikawaDepartment of Medical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Ryo ShintateDepartment of Medical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Manami MiyashitaDepartment of Medical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.
Yoshiaki TsubataAdvanced Materials Development Laboratory, Sumitomo Chemical Co., Ltd., 6, Kitahara, Tsukuba, Ibaraki, 300-3294, Japan.
Kouichi SaitoAdvanced Materials Development Laboratory, Sumitomo Chemical Co., Ltd., 6, Kitahara, Tsukuba, Ibaraki, 300-3294, Japan.
Miya IshiharaDepartment of Medical Engineering, National Defense Medical College, 3-2 Namiki, Tokorozawa, Saitama, 359-8513, Japan.ORCID https://orcid.org/0000-0001-6362-5014

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Although second near-infrared (NIR-II) photoacoustic (PA) imaging affords deep tissue penetration, developing efficient contrast agents remains challenging due to a lack of suitable optical absorbers. Herein, we report semiconducting polymer nanoparticles (SPNs) for dual-modal PA and NIR fluorescence imaging, featuring a high optical absorption coefficient at 1064 nm that facilitates excitation via high-power Nd:YAG lasers. Phantom evaluations revealed a linear PA signal correlation, with a low detection limit of 0.05 cm

Identifiers

PMID42609955
PMCPMC13481065

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.